It was an incredibly insightful event, and we were thrilled to witness the integration of diabetes and obesity care into a unified approach for enhancing patient well-being. While GLP-1 receptor agonists have been available in diabetes care for some time, with 2nd and 3rd generation medications showing significant weight loss, we are seeing the need now more than ever to monitor body composition!
We were encouraged to see ADA speakers moving away from using weight or BMI only and including body composition analysis in their studies and practices. Relying more on body composition outcomes helps to personalize care and motivate patients to continue managing their chronic health conditions.
We were happy to have Dr. Nina Crowley attend the show along with our Sales, Marketing, and Product Management teams. They shared some fascinating takeaways that we think you’ll find valuable. Check out some of their highlights below!
Optimizing GLIP-1/GIP Receptor Agonists for Patient Success
Dr. Crowley highlighted the symposium by dietitians Maureen Chomko and Colleen Dawkins on Optimizing Outcomes of GLIP-1/GIP Receptor Agonists. The focus was on evidence-based practices to help patients stay on medications, manage costs and side effects, and ensure patient satisfaction. Key points included:
Dr. Beverly Tchang’s talk on Fine Tuning the Patient’s GLP-1 Experience emphasized using patient-first language and discussing the 4Cs: Contraindications, Comorbidities, Cost, and Choice. The discussion revolved around appetite cues, meal timing, and hydration, underscoring the role of nutrition in the care of patients on these medications. This further supports the need for a comprehensive care team to manage patients on obesity medications and underlies the need for research on side effects of medications and the patient’s experience.
We are grateful for the opportunity to connect with so many dedicated professionals at the ADA’s 84th Scientific Sessions. Your enthusiasm and commitment to improving patient care inspire us. As we continue to explore the intersection of diabetes and obesity care, we look forward to collaborating with you to advance the use of body composition analysis in clinical practice. Keep an eye out for our upcoming blog post with a detailed recap of the event, and don’t miss our gallery of moments captured during the sessions. Until next time, let’s keep pushing the boundaries of patient care together!
In this episode of 'In the Know with Nina,' Dr. Nina Crowley and Dr. Colleen Tewksbury explore nutritional considerations for patients on anti-obesity medications. They discuss practical guidance for general practitioners, emphasizing patient-centered care, empathetic support, and the potential impact of these medications on obesity treatment.
Watch episodeJoin Dr. Nina Crowley on The Nourished Child Podcast as she delves into the psychology of eating habits. Learn how to promote healthy relationships with food, address diet culture, and empower children with balanced eating habits. Perfect for parents seeking mindful approaches to nutrition and body image.
Watch episodeDr. Nina Crowley chats with Dr. Renee Rogers, PhD, FACSM, at ACSM 2024, discussing person-centered obesity care, exercise physiology, and behavior change. Renee highlights her research and clinical insights on integrating physical activity with contemporary anti-obesity medications.
Watch episodeMedical Measuring Systems and Scales since 1840
13601 Benson AvenueAs the world leader in medical scales, we also offer you first-class service. Together with our branches, partners and dealers, seca offers a worldwide service network that ensures our products work troublefree.
All rights reserved seca 2023